載入...
Analysis of the CDK4/6 Cell Cycle Pathway in Leiomyosarcomas as a Potential Target for Inhibition by Palbociclib
Leiomyosarcoma (LMS) is characterized by high genomic complexity, and to date, no specific targeted therapy is available. In a genome-wide approach, we profiled genomic aberrations in a small cohort of eight primary tumours, two relapses, and eight metastases across nine different patients. We ident...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Hindawi Limited
2019-01-01
|
| 叢編: | Sarcoma |
| 在線閱讀: | http://dx.doi.org/10.1155/2019/3914232 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|